Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DCVAC/PCa added onto hormone therapy can
improve PSA progression times for patients with Metastatic Prostate Cancer.